Skip to content

Michael Brinkenhoff

Director at RLL Bio.

Earliest Form D on file: Apr 2026

Filed Apr 6, 2026

RLL Bio

Oral drug that blocks cancer cell DNA repair and growth

Biotech, Lutherville MD

Named, Director.

$2M

sold

Form D

Network

At RLL Bio

4 people